The Optimal Timing of the Initiation of Esophagogastroduodenoscopy After Oral Lidocaine Spray

Launched by NATIONAL CHENG-KUNG UNIVERSITY HOSPITAL · Jul 9, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the best timing for starting an esophagogastroduodenoscopy (EGD) after using a local numbing spray called lidocaine. The EGD is a procedure that helps doctors look at the upper part of the digestive system, and it can be uncomfortable for some patients. Using lidocaine spray can help make the procedure easier for patients by reducing discomfort, but it’s not clear how long doctors should wait after applying the spray before starting the exam. The goal of this trial is to find out the optimal waiting time to ensure the best possible experience and results for patients.

To be eligible for this trial, participants should be 20 years or older and scheduled for an EGD due to issues like stomach pain, ulcers, or acid reflux. However, patients with certain conditions, such as gastrointestinal bleeding or those needing more complicated procedures, cannot participate. If you join the study, you will receive the lidocaine spray and then undergo the EGD at different times to see which timing works best for your comfort and the exam’s effectiveness. This research aims to improve the experience for future patients undergoing this important procedure.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Eligible participants included patients aged ≥ 20 years who scheduled EGD from OPD for dyspepsia, peptic ulcer disease, GERD, subepithelial lesion evaluation, and diarrhea
• Exclusion Criteria:
• • GI bleeding
• • endoscopic submucosal dissection due to prolonged scheduled procedure time
• • patients from emergency department or ward